• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0301
Device Problem Difficult to Advance (2920)
Patient Problem Atrial Perforation (2511)
Event Date 09/12/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all relevant information.The second mitraclip clip delivery system is filed under a separate medwatch report number.
 
Event Description
This is filed to report the septal tear.It was reported that this was a mitraclip procedure to treat grade 4 degenerative mitral regurgitation (mr).The first mitraclip was advanced beneath the mitral valve.When it was pulled back to the left atrium, the height of the device was lower than it had been.The height was rechecked and it was suspected that there was a tear in the septum causing the lower height.Some adjustments were made to the position of the sgc (steerable guide catheter) to compensate for the tear in the septum and lost height.There was left to right shunting and the atrial septal defect was larger than expected, but no treatment was required.The procedure continued with deployment of the first mitraclip reducing mr to grade 2 to 3.When the second mitraclip was exiting the sgc into the left atrium, the patient went into ventricular fibrillation so the second undeployed clip was removed.The ventricular fibrillation was treated with defibrillation.The patient was stabilized but the procedure was aborted.Air embolism was suspected to be the cause of the ventricular fibrillation, but no air was visible.There were no issues using the mitraclip devices.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Review of the complaint history identified no similar incidents from this lot.The reported difficult to position the steerable guide catheter (sgc) appears to be due to the user technique/procedural circumstances as the unexpected movement/steering of the device appears to have influenced the reported adverse event.The atrial septal defect (atrial perforation) was a result of procedural circumstances as the sgc was observed to have lost height.The reported patient effect of atrial septal defect, as listed in the mitraclip system instructions for use is a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to design, manufacturing, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key7928133
MDR Text Key122444238
Report Number2024168-2018-07618
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/03/2018
Device Catalogue NumberSGC0301
Device Lot Number71002U246
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/12/2018
Initial Date FDA Received10/02/2018
Supplement Dates Manufacturer Received12/07/2018
Supplement Dates FDA Received12/14/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
TWO CLIP DELIVERY SYSTEMS
Patient Outcome(s) Other;
Patient Age83 YR
Patient Weight74
-
-